T46.2X5A — Adverse effect of other antidysrhythmic drugs, initial encounter
Is T46.2X5A billable?
Yes — T46.2X5A is billable for FY2027. T46.2X5A is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. T46.2X5A may be submitted for encounters from October 1, 2026 through September 30, 2027.
T46.2X5A at a glance
| Code | T46.2X5A |
|---|---|
| Description | Adverse effect of other antidysrhythmic drugs, initial encounter |
| Billable | Yes |
| Code set | ICD-10-CM FY2027 |
| Valid for encounters | October 1, 2026 – September 30, 2027 |
| 7th character "A" | initial encounter |
What does the 7th character "A" mean in T46.2X5A?
In T46.2X5A, the 7th character A means initial encounter. The 7th character is required for T46.2X5A to be a valid, complete code.
Same condition, different episode of care — switch the 7th character:
What Medicare edits apply to T46.2X5A?
The Medicare Code Editor screens inpatient claims before they are grouped. These edits name T46.2X5A directly.
CMS will reject this code as the principal diagnosis on an inpatient claim. It describes something other than the condition chiefly responsible for the admission.
Which MS-DRGs does T46.2X5A group to?
T46.2X5A sits in MDC 15 and helps define the logic of 1 MS-DRG (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.
- 791Prematurity with Major Problemsmedical
Excludes1 — never code together — inherited from T36-T50
The conditions below can never be reported together with T46.2X5A on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.
- toxic reaction to local anesthesia in pregnancy (O29.3-)
Excludes1 — never code together — inherited from T46
The conditions below can never be reported together with T46.2X5A on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.
- poisoning by, adverse effect of and underdosing of metaraminol (T44.4)
Excludes1 — never code together — inherited from T46.2
The conditions below can never be reported together with T46.2X5A on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.
- poisoning by, adverse effect of and underdosing of beta-adrenoreceptor antagonists (T44.7-)
Code first — inherited from T36-T50
The underlying condition below must be sequenced before T46.2X5A. T46.2X5A describes a manifestation and cannot be the principal or first-listed diagnosis.
Use additional code — inherited from Chapter 19
Report an additional code alongside T46.2X5A to fully describe the condition. T46.2X5A is sequenced first.
- code to identify any retained foreign body, if applicable (Z18.-)
Use additional code — inherited from T36-T50
Report an additional code alongside T46.2X5A to fully describe the condition. T46.2X5A is sequenced first.
Excludes2 — not included here — inherited from Chapter 19
The conditions below are not part of T46.2X5A, but a patient may have both at the same time. When documentation supports it, T46.2X5A and the excluded code may both be reported.
Excludes2 — not included here — inherited from T36-T50
The conditions below are not part of T46.2X5A, but a patient may have both at the same time. When documentation supports it, T46.2X5A and the excluded code may both be reported.
How long has T46.2X5A existed?
T46.2X5A has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.
Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.